RESPIRATORY SYNCYTIAL VIRUS (RSV)
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS (RSV) explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS (RSV) trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pfizer checks if Mom's shot shields newborns from dangerous RSV
⭐️ VACCINE ⭐️ OngoingThis study aims to see how well a vaccine (ABRYSVO) given to pregnant women works in the real world to protect their babies from being hospitalized with severe RSV lung infections. Researchers will look at the medical records of babies under 1 year old who were hospitalized in Au…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 24, 2026 12:02 UTC
-
Can a Mom's shot shield her baby from RSV?
⭐️ VACCINE ⭐️ OngoingThis study is checking how well the ABRYSVO RSV vaccine works when given to pregnant people to protect their babies after birth. Researchers will review the medical records of nearly 40,000 mothers and infants to compare health outcomes for babies whose mothers got the vaccine ve…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 23, 2026 15:17 UTC
-
Scientists map Body's defense after RSV shot
Knowledge-focused OngoingThis study aims to understand how the immune systems of adults aged 60 and older respond to the FDA-approved Moderna RSV vaccine. Researchers will collect detailed biological data from 14 participants to identify early signs of a strong immune response and learn how long protecti…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE4 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC